Combinational phototherapy and hypoxia-activated chemotherapy favoring antitumor immune responses

References

• Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997;337:956–962. doi:10.1056/NEJM1997100233714029309100
   PubMed Web of Science ®Google Scholar
• Chen W, Ouyang J, Liu H, et al. Black phosphorus nanosheet-based drug delivery system for synergistic photodynamic/photothermal/chemotherapy of cancer. Adv Mater. 2017;29:1603864. doi:10.1002/adma.201700681
   Web of Science ®Google Scholar
• Ouyang J, Wang L, Chen W, et al. Biomimetic nanothylakoids for efficient imaging-guided photodynamic therapy for cancer. Chem Commun. 2018;54:3468–3471. doi:10.1039/C8CC00674A
   PubMed Web of Science ®Google Scholar
• Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol. 2016;13:674–690. doi:10.1038/nrclinonc.2016.6627184417
   PubMed Web of Science ®Google Scholar
• Zeng K, Xu Q, Ouyang J, et al. Coordination nanosheets of phthalocyanine as multifunctional platform for imaging-guided synergistic therapy of cancer. ACS Appl Mater Interfaces. 2019;11:6840–6849. doi:10.1021/acsami.8b2200830693749
   PubMedGoogle Scholar
• Ren S, Yang J, Ma L, et al. Ternary-responsive drug delivery with activatable dual mode contrast-enhanced in vivo imaging. ACS Appl Mater Interfaces. 2018;10:31947–31958. doi:10.1021/acsami.8b1056430179443
   PubMedGoogle Scholar
• De Palma M, Biziato D, Petrova TV. Microenvironmental regulation of tumour angiogenesis. Nat Rev Cancer. 2017;17:457–474. doi:10.1038/nrc.2017.5128706266
   PubMed Web of Science ®Google Scholar
• Ouyang J, Deng Y, Chen W, et al. Marriage of artificial catalase and black phosphorus nanosheets for reinforced photodynamic antitumor therapy. J Mater Chem B. 2018;6:2057–2064. doi:10.1039/C8TB00371H
   PubMed Web of Science ®Google Scholar
• Demaria S, Kawashima N, Yang AM, et al. Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. Clin Cancer Res. 2005;11:728–734.15701862
   PubMed Web of Science ®Google Scholar
• Sandip Pravin P, Razelle K. PD-L1 expression as a predictive biomarker in cancer immunotherapy. Mol Cancer Ther. 2015;14:847–856. doi:10.1158/1535-7163.MCT-14-098325695955
   PubMedGoogle Scholar
• Wang X, Li X, Ito A, Sogo Y, Ohno T. Particle-size-dependent toxicity and immunogenic activity of mesoporous silica-based adjuvants for tumor immunotherapy. Acta Biomater. 2013;9:7480–7489. doi:10.1016/j.actbio.2013.03.03123541601
   PubMed Web of Science ®Google Scholar
• Jen-Chieh T, Brandi L, Alicia H, et al. Systemic tumor targeting and killing by sindbis viral vectors. Nat Biotechnol. 2004;22:70–77. doi:10.1038/nbt91714647305
   PubMedGoogle Scholar
• Carpenter RA, Kwak JG, Peyton SR, Lee J. Implantable pre-metastatic niches for the study of the microenvironmental regulation of disseminated human tumour cells. Nat Biomed Eng. 2018;2:915–929. doi:10.1038/s41551-018-0307-x30906645
   PubMed Web of Science ®Google Scholar
• Yu C, Xu L, Chao L, et al. Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumour responses. Nat Biomed Eng. 2018;2:611–621. doi:10.1038/s41551-018-0262-631015634
   PubMedGoogle Scholar
• Li Y, He L, Dong H, et al. Fever-inspired immunotherapy based on photothermal cpg nanotherapeutics: the critical role of mild heat in regulating tumor microenvironment. Adv Sci. 2018;5:1700805–1700816. doi:10.1002/advs.201700805
   Web of Science ®Google Scholar
• Chiang CS, Lin YJ, Lee R, et al. Combination of fucoidan-based magnetic nanoparticles and immunomodulators enhances tumour-localized immunotherapy. Nat Nanotechnol. 2018;13:746–754. doi:10.1038/s41565-018-0146-729760523
   PubMed Web of Science ®Google Scholar
• Kim DH, Han JS, Ly P, et al. TRIP13 and APC15 drive mitotic exit by turnover of interphase-and unattached kinetochore-produced MCC. Nat Commun. 2018;9:4354–4364.30341343
   PubMed Web of Science ®Google Scholar
• Adachi K, Kano Y, Nagai T, Okuyama N, Sakoda Y, Tamada K. IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor. Nat Biotechnol. 2018;36:346–351. doi:10.1038/nbt.408629505028
   PubMed Web of Science ®Google Scholar
• Smith TT, Stephan SB, Moffett HF, et al. In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers. Nat Nanotechnol. 2017;12:813–820. doi:10.1038/nnano.2017.5728416815
   PubMed Web of Science ®Google Scholar
• Rodell CB, Arlauckas SP, Cuccarese MF, et al. TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy. Nat Biomed Eng. 2018;2:578–588.
   PubMed Web of Science ®Google Scholar
• Chen Q, Xu L, Liang C, Wang C, Peng R, Liu Z. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy. Nat Commun. 2016;7:13193. doi:10.1038/ncomms1319327767031
   PubMed Web of Science ®Google Scholar
• Heidi L. Immunotherapy‘s cancer Remit Widens. Nature. 2013;497:544.23719439
   PubMed Web of Science ®Google Scholar
• Liang R, Liu L, He H, et al. Oxygen-boosted immunogenic photodynamic therapy with gold nanocages@manganese dioxide to inhibit tumor growth and metastases. Biomaterials. 2018;177:149–160. doi:10.1016/j.biomaterials.2018.05.05129890364
   PubMed Web of Science ®Google Scholar
• Wong ML, Griffiths LG. Immunogenicity in xenogeneic scaffold generation: antigen removal vs. decellularization. Acta Biomater. 2014;10:1806–1816. doi:10.1016/j.actbio.2014.01.02824486910
   PubMed Web of Science ®Google Scholar
• Duan X, Chan C, Lin W. Nanoparticle-mediated immunogenic cell death enables and potentiates cancer immunotherapy. Angew Chem Int Ed. 2018;58:670–680. doi:10.1002/anie.201804882
   PubMed Web of Science ®Google Scholar
• Kepp O, Galluzzi L, Martins I, et al. Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. Cancer Metastasis Rev. 2011;30:61–69. doi:10.1007/s10555-011-9273-421249425
   PubMed Web of Science ®Google Scholar
• Lu J, Liu X, Liao YP, et al. Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression. Nat Commun. 2017;8:1811. doi:10.1038/s41467-017-01651-929180759
   PubMed Web of Science ®Google Scholar
• Yang C, Chen Y, Wei G, et al. Bismuth ferrite-based nanoplatform design: an ablation mechanism study of solid tumor and NIR-triggered photothermal/photodynamic combination cancer therapy. Adv Funct Mater. 2018;28:1706827. doi:10.1002/adfm.201706827
   Web of Science ®Google Scholar
• Su YL, Hu SH. Functional nanoparticles for tumor penetration of therapeutics. Pharmaceutics. 2018;10:193. doi:10.3390/pharmaceutics10040193
   PubMed Web of Science ®Google Scholar
• Wang C, Xu L, Liang C, Xiang J, Peng R, Liu Z. Immunological responses triggered by photothermal therapy with carbon nanotubes in combination with anti-CTLA-4 therapy to inhibit cancer metastasis. Adv Mater. 2014;26:8154–8162. doi:10.1002/adma.20140299625331930
   PubMed Web of Science ®Google Scholar
• Dong K, Liu Z, Liu J, et al. Biocompatible and high-performance amino acids-capped MnWO4 nanocasting as a novel non-lanthanide contrast agent for X-ray computed tomography and T(1)-weighted magnetic resonance imaging. Nanoscale. 2014;6:2211–2217. doi:10.1039/c3nr05455a24382605
   PubMedGoogle Scholar
• Li T, Yan L. Functional polymer nanocarriers for photodynamic therapy. Pharmaceuticals. 2018;11:133. doi:10.3390/ph11040133
   Web of Science ®Google Scholar
• Liu Z, Liu J, Wang R, Du Y, Ren J, Qu X. An efficient nano-based theranostic system for multi-modal imaging-guided photothermal sterilization in gastrointestinal tract. Biomaterials. 2015;56:206–218. doi:10.1016/j.biomaterials.2015.04.00525934293
   PubMedGoogle Scholar
• Yang Z, Liu T, Xie Y, et al. Chitosan layered gold nanorods as synergistic therapeutics for photothermal ablation and gene silencing in triple-negative breast cancer. Acta Biomater. 2015;25:194–204. doi:10.1016/j.actbio.2015.07.02626193000
   PubMed Web of Science ®Google Scholar
• Chen Y, Li H, Deng Y, Sun H, Ke X, Ci T. Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment. Acta Biomater. 2017;51:374–392. doi:10.1016/j.actbio.2016.12.00428088668
   PubMed Web of Science ®Google Scholar
• Sweeney EE, Cano-Mejia J, Fernandes R. Photothermal therapy generates a thermal window of immunogenic cell death in neuroblastoma. Small. 2018;14:e1800678. doi:10.1002/smll.v14.2029665282
   PubMed Web of Science ®Google Scholar
• Lu J, Liu X, Liao YP, et al. Breast cancer chemo-immunotherapy through liposomal delivery of an immunogenic cell death stimulus plus interference in the IDO-1 pathway. ACS Nano. 2018;12:11041–11061. doi:10.1021/acsnano.8b0518930481959
   PubMed Web of Science ®Google Scholar
• Adkins I, Fucikova J, Garg AD, Agostinis P, Špíšek R. Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy. Oncoimmunology. 2014;3:e968434. doi:10.4161/21624011.2014.96843425964865
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang D, Yang K, et al. Mitochondria-targeted artificial “nano-RBCs” for amplified synergistic cancer phototherapy by a single NIR irradiation. Adv Sci. 2018;5:1800049–1800063. doi:10.1002/advs.201800049
   Web of Science ®Google Scholar
• Spring BQ, Sears RB, Zheng LZ, et al. A photoactivable multi-inhibitor nanoliposome for tumour control and simultaneous inhibition of treatment escape pathways. Nat Nanotechnol. 2016;11:378–387. doi:10.1038/nnano.2015.31126780659
   PubMed Web of Science ®Google Scholar
• Liu LH, Zhang YH, Qiu WX, et al. Dual-stage light amplified photodynamic therapy against hypoxic tumor based on an O2 self-sufficient nanoplatform. Small. 2017;13:1701621. doi:10.1002/smll.201701621
   Web of Science ®Google Scholar
• Peng C-L, Shih Y-H, Lee P-C, Hsieh H, Luo T-Y, Shieh M-J. Multimodal image-guided photothermal therapy mediated by 188re-labeled micelles containing a cyanine-type photosensitizer. ACS Nano. 2011;5:5594–5607. doi:10.1021/nn201100m21671580
   PubMed Web of Science ®Google Scholar
• Alves CG, Lima-Sousa R, Melo-Diogo DD, Louro RO, Correia IJ. IR780 based nanomaterials for cancer imaging and photothermal, photodynamic and combinatorial therapies. Int J Pharm. 2018;542:164–175. doi:10.1016/j.ijpharm.2018.03.02029549013
   PubMed Web of Science ®Google Scholar
• Yang Y, Yang X, Li H, et al. Near-infrared light triggered liposomes combining photodynamic and chemotherapy for synergistic breast tumor therapy. Colloids Surf B. 2019;173:564–570. doi:10.1016/j.colsurfb.2018.10.019
   PubMed Web of Science ®Google Scholar
• Brown JM, Wilson WR. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer. 2004;4:437–447. doi:10.1038/nrc136715170446
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu Y, Bu W, et al. Hypoxia induced by upconversion-based photodynamic therapy: towards highly effective synergistic bioreductive therapy in tumors. Angew Chem Int Ed. 2015;54:8105–8109. doi:10.1002/anie.201500478
   PubMed Web of Science ®Google Scholar
• Anderson RF, Shinde SS, Hay MP, Gamage SA, Denny WA. Activation of 3-amino-1, 2, 4-benzotriazine 1, 4-dioxide antitumor agents to oxidizing species following their one-electron reduction. J Am Chem Soc. 2003;125:748–756. doi:10.1021/ja020936312526674
   PubMed Web of Science ®Google Scholar
• Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annu Rev Immunol. 2013;31:51–72. doi:10.1146/annurev-immunol-032712-10000823157435
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Immunogenic cell death in cancer and infectious disease. Nat Rev Immunol. 2016;17:97–111. doi:10.1038/nri.2016.10727748397
   PubMedGoogle Scholar
• Kepp O, Senovilla L, Vitale I, et al. Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology. 2014;3:e955691. doi:10.4161/21624011.2014.95569125941621
   PubMed Web of Science ®Google Scholar
• Garg AD, Agostinis P. Editorial: immunogenic cell death in cancer: from Benchside research to bedside reality. Front Immunol. 2016;7:110. doi:10.3389/fimmu.2016.0011027066003
   PubMed Web of Science ®Google Scholar
• Apetoh L, Ghiringhelli F, Tesniere A, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med. 2007;13:1050–1059. doi:10.1038/nm162217704786
   PubMed Web of Science ®Google Scholar
• Casares N, Pequignot MO, Antoine T, et al. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med. 2005;202:1691–1701. doi:10.1084/jem.2005091516365148
   PubMed Web of Science ®Google Scholar
• Zhao P, Ren S, Liu Y, Huang W, Zhang C, He J. PL-W18O49-TPZ nanoparticles for simultaneous hypoxia-activated chemotherapy and photothermal therapy. ACS Appl Mater Interfaces. 2018;10:3405–3413. doi:10.1021/acsami.7b1732329313656
   PubMedGoogle Scholar
• Le KT, Yu JH, Jun H, et al. Polyglycerolated nanocarriers with increased ligand multivalency for enhanced in vivo therapeutic efficacy of paclitaxel. Biomaterials. 2017;43:223–232.
   Google Scholar
• Jiang C, Cheng H, Yuan A, Tang X, Wu J, Hu Y. Hydrophobic IR780 encapsulated in biodegradable human serum albumin nanoparticles for photothermal and photodynamic therapy. Acta Biomater. 2015;14:61–69. doi:10.1016/j.actbio.2014.11.04125463484
   PubMed Web of Science ®Google Scholar
• Wang S, Shang L, Li L, et al. Metal-organic-framework-derived mesoporous carbon nanospheres containing porphyrin-like metal centers for conformal phototherapy. Adv Mater. 2016;28:8379–8387. doi:10.1002/adma.20160219727461987
   PubMed Web of Science ®Google Scholar
• Ren H, Liu J, Su F, et al. Relighting photosensitizers by synergistic integration of albumin and perfluorocarbon for enhanced photodynamic therapy. ACS Appl Mater Interfaces. 2017;9:3463−3473. doi:10.1021/acsami.6b1488528067039
   PubMed Web of Science ®Google Scholar
• Luo Z, Wang C, Yi H, et al. Nanovaccine loaded with poly I:C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in vivo. Biomaterials. 2015;38:50–60. doi:10.1016/j.biomaterials.2014.10.05025457983
   PubMed Web of Science ®Google Scholar
• Qian C, Feng P, Yu J, et al. Anaerobe-inspired anticancer nanovesicles. Angew Chem Int Ed. 2017;56:2588–2593. doi:10.1002/anie.201611783
   PubMed Web of Science ®Google Scholar